Literature DB >> 27780737

Rat NEURL1 3'UTR is alternatively spliced and targets mRNA to dendrites.

Madis Jaagura1, Kati Taal1, Indrek Koppel1, Jürgen Tuvikene1, Tõnis Timmusk2, Richard Tamme3.   

Abstract

Neuralized, an E3 ubiquitin ligase, interacts with and positively modulates the Notch pathway by promoting ubiquitination and subsequent endocytosis of its ligands. NEURL1 mRNA is dendritically localised in the dentate gyrus of an adult rat brain, implying that it may be locally translated, but its transport mechanisms remain unstudied. Here, we report the presence of a previously unknown, shorter splice-variant of rat NEURL1 3'UTR (1477bp in length), and identify it as a potential target of nonsense-mediated decay. We show that endogenous NEURL1 mRNAs with both longer and shorter 3'UTRs are enriched in the neurites of cultured rat primary hippocampal neurons. Both NEURL1 3'UTRs can mediate transport of reporter mRNAs into dendrites in primary hippocampal neurons. By analysing the dendritic trafficking capacity of reporter mRNAs linked to various regions of longer or shorter NEURL1 3'UTR, we localise the dendritic targeting element (DTE) of spliced version of NEURL1 3'UTR to its first half, corresponding to the nucleotides 1-148 and 416-914 of the full-length 3'UTR. In contrast, the dendritic targeting capacity of the full-length NEURL1 3'UTR is abolished by splitting its 3'UTR in two halves (nt 1-914 and nt 915-1744), suggesting that slightly different DTE might mediate dendritic transport of the two transcripts.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Alternative splicing in 3′UTR; Dendritic targeting; Neuralized-like 1; Nonsense-mediated decay

Mesh:

Substances:

Year:  2016        PMID: 27780737     DOI: 10.1016/j.neulet.2016.10.041

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  1 in total

1.  AR mRNA stability is increased with AR-antagonist resistance via 3'UTR variants.

Authors:  D A Dart; K Ashelford; W G Jiang
Journal:  Endocr Connect       Date:  2020-01       Impact factor: 3.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.